Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

DSpace Repositorium (Manakin basiert)

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

Autor(en): Hermine, Olivier; Hoster, Eva; Walewski, Jan; Bosly, Andre; Stilgenbauer, Stephan; Thieblemont, Catherine; Szymczyk, Michal; Bouabdallah, Reda; Kneba, Michael; Hallek, Michael; Salles, Gilles; Feugier, Pierre; Ribrag, Vincent; Birkmann, Josef; Forstpointner, Roswitha; Haioun, Corinne; Haenel, Mathias; Casasnovas, Rene Olivier; Finke, Juergen; Peter, Norma; Bouabdallah, Kamal; Sebban, Catherine; Fischer, Thomas; Duehrsen, Ulrich; Metzner, Bernd; Maschmeyer, Georg; Kanz, Lothar; Schmidt, Christian; Delarue, Richard; Brousse, Nicole; Klapper, Wolfram; Macintyre, Elizabeth; Delfau-Larue, Marie-Helene; Pott, Christiane; Hiddemann, Wolfgang; Unterhalt, Michael; Dreyling, Martin
Tübinger Autor(en):
Kanz, Lothar
Erschienen in: Lancet (2016), Bd. 388, H. 10044, S. 565-575
Verlagsangabe: Elsevier Science Inc
Sprache: Englisch
Referenz zum Volltext: http://dx.doi.org/10.1016/S0140-6736(16)00739-X
ISSN: 1474-547X
DDC-Klassifikation: 610 - Medizin, Gesundheit
Dokumentart: Wissenschaftlicher Artikel
Zur Langanzeige

Das Dokument erscheint in: